- $15.14bn
- $18.20bn
- $2.40bn
- 67
- 21
- 95
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,096 | 2,113 | 5,349 | 1,893 | 2,396 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 968 | 416 | 917 | 1,945 | 2,364 |
Operating Profit | 1,127 | 1,697 | 4,433 | -52 | 32.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,186 | 1,449 | 4,665 | -23.8 | 83.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,180 | 1,439 | 4,656 | -56.2 | 23.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 471 | 732 | 2,181 | 92.4 | 80.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 481 | 928 | 2,026 | 87.4 | 71.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 1.72 | 6.56 | 0.283 | 0.232 |
Dividends per Share |